Sterne Agee reduces its rating on athenahealth ATHN from Neutral to Underperform and lowers its price target from $71 to $68.
Sterne Agee says, "Our downgrade rests on the belief that ATHN's ability to expand margins will be hampered by the increasing labor costs necessary to handle a growing installed base on , thus suppressing margin expansion going forward."
ATHN closed at $85.44 on Tuesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in